Why is Lincoln Pharmaceuticals Ltd falling/rising?

Strong Recent Performance and Market Outperformance

Lincoln Pharmaceuticals has demonstrated remarkable gains over the past week and month, with returns of 31.16% and 25.02% respectively, vastly outpacing the Sensex which recorded marginal changes of +0.43% and -0.24% over the same periods. Year-to-date, the stock has appreciated by 25.08%, while the Sensex declined by 1.81%, underscoring the stock’s resilience and investor favour amid broader market weakness. This recent rally is particularly notable given the stock’s one-year return of -8.51%, which contrasts with the Sensex’s positive 9.85% gain, suggesting a strong reversal in sentiment towards Lincoln Pharmaceuticals.

The stock’s five-year performance further highlights its long-term strength, having delivered a cumulative return of 175.10%, nearly triple the Sensex’s 62.34% gain, reflecting sustained growth and value creation for shareholders over the medium to long term.

Intraday Volatility and Trading Dynamics

On 12-Feb, Lincoln Pharmaceuticals exhibited high intraday volatility, with a price range spanning ₹149.25, from a low of ₹488 to a high of ₹637.25, representing an intraday swing of approximately 20%. The stock opened with a gap up of 2.5%, signalling strong buying interest from the outset. Despite the wide trading range, the weighted average price indicates that a greater volume of shares exchanged hands closer to the lower end of the day’s price spectrum, suggesting some profit-taking or cautious trading amid the volatility.

Notably, the stock has been on a four-day consecutive gain streak, accumulating a 31.33% return during this period. This sustained upward momentum is further supported by the stock trading above all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – which technical analysts often interpret as a bullish signal indicating strong underlying demand and positive investor sentiment.

However, investor participation appears to be moderating, with delivery volume on 11 Feb falling by 28.79% compared to the five-day average. This decline in delivery volume may indicate that while the stock price is rising, fewer investors are holding shares for the longer term, potentially reflecting short-term speculative interest or profit booking by some participants.

Liquidity and Trading Suitability

Liquidity remains adequate for trading, with the stock’s average traded value supporting trade sizes of approximately ₹0.03 crore based on 2% of the five-day average traded value. This level of liquidity ensures that investors can enter and exit positions without significant price impact, which is favourable for both retail and institutional participants.

Conclusion: Why Lincoln Pharmaceuticals Is Rising

The sharp rise in Lincoln Pharmaceuticals’ share price on 12-Feb can be attributed to a combination of strong recent price momentum, significant outperformance relative to the Sensex and its sector, and positive technical indicators such as trading above all major moving averages. The stock’s ability to sustain gains over multiple days and its substantial returns over the past week and month highlight renewed investor confidence. While intraday volatility and a decline in delivery volumes suggest some caution among participants, the overall trend remains bullish.

Investors should note the stock’s wide intraday price swings and moderate liquidity, which may present both opportunities and risks depending on individual trading strategies. The stock’s long-term performance record also provides a backdrop of solid growth, reinforcing its appeal as a growth-oriented pharmaceutical company within the Indian market.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →